Creon and Suprax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Creon (pancrelipase (amylase;lipase;protease)) and Suprax (cefixime). Common drug interactions include abdominal distension among females and haematotoxicity among males.

The phase IV clinical study analyzes what interactions people have when they take Creon and Suprax. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Creon?

Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 29,489 Creon users. Check the latest studies of Creon.

What is Suprax?

Suprax has active ingredients of cefixime. eHealthMe is studying from 965 Suprax users. Check the latest studies of Suprax.

On Jul, 26, 2026

16 people who take Creon and Suprax together, and have interactions are studied.

What are the common drug interactions of Creon and Suprax, by gender? *:

female:

Abdominal distension
Hyperglycaemia (high blood sugar)
Pyrexia (fever)
Cough
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Upper respiratory tract infection
Viral infection

male:

Haematotoxicity (toxins that destroy red blood cells)
Nausea (feeling of having an urge to vomit)
Cough
Decreased activity
Emotional distress
Fracture
Intestinal obstruction
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain

What are the common drug interactions of Creon and Suprax, by age (0-1 to 60+)? *:

0-1:

Cough
Upper respiratory tract infection
Viral infection

2-9:

Haematotoxicity (toxins that destroy red blood cells)
Nausea (feeling of having an urge to vomit)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Vomiting
Hyperkalaemia (damage to or disease of the kidney)
Sinus arrhythmia (a naturally occurring variation in heart rate that occurs during a breathing cycle)

10-19:

Nasopharyngitis (inflammation of the nasopharynx)
Sinusitis (inflammation of sinus)

20-29:

Cough
Intestinal obstruction

30-39:

Abdominal distension
Gastrointestinal disorder (functional problems of gastrointestinal tract)

40-49:

n/a

50-59:

Pain
Quality of life decreased
Renal failure (kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone disorder
Decreased activity
Emotional distress
Fracture
Osteopenia (a condition where bone mineral density is lower than normal)

60+:

Hyperglycaemia (high blood sugar)
Pyrexia (fever)

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 10 people, 62.50%
Urinary Tract Infection: 3 people, 18.75%
Tumor: 3 people, 18.75%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 3 people, 18.75%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 12.50%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 2 people, 12.50%
Cholangitis (infection of the bile duct): 2 people, 12.50%
Gastritis (inflammation of stomach): 2 people, 12.50%
Anaemia (lack of blood): 2 people, 12.50%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Creon and Suprax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously